UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease

Gut, 2009-12, Vol.58 (12), p.1629-1636

2009

Volltextzugriff (PDF)

Serum regenerating islet‐derived 3‐alpha is a biomarker of mucosal enteropathies

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (8), p.974-981

2014

Volltextzugriff (PDF)

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease

Mucosal immunology, 2011-09, Vol.4 (5), p.574-583

2011

Volltextzugriff (PDF)

OC.02.2 HUMAN NEUTROPHIL ELASTASE CONTRIBUTES TO LOSS OF FUNCTION OF INFLIXIMAB IN ULCERATIVE COLITIS

Digestive and liver disease, 2016-02, Vol.48, p.e75-e76

2016

Volltextzugriff (PDF)

V.01.3 CHOLANGIOSCOPIC REMOVAL OF POST-CHOLECYSTECTOMY SURGICAL CLIPS MIGRATED INTO THE COMMON HEPATIC DUCT

Digestive and liver disease, 2023-03, Vol.55, p.S192-S193

2023

Volltextzugriff (PDF)

P.06.8 T HELPER 2 CELLS ARE NOT INCREASED, WHEREAS NATURAL KILLER T CELLS ARE REDUCED IN THE INFLAMED MUCOSA OF ULCERATIVE COLITIS PATIENTS

Digestive and liver disease, 2014-03, Vol.46, p.S73-S73

2014

Volltextzugriff (PDF)

OC.16.3 THE ROLE OF HUMAN NEUTROPHIL ELASTASE AND ITS INHIBITOR ELAFIN IN ULCERATIVE COLITIS

Digestive and liver disease, 2014-03, Vol.46, p.S35-S35

2014

Volltextzugriff (PDF)

P.11.1 THYMIC STROMAL LYMPHOPOIETIN IS PRIMARILY REDUCED IN REFRACTORY COELIAC DISEASE DUODENAL MUCOSA

Digestive and liver disease, 2014-03, Vol.46, p.S94-S95

2014

Volltextzugriff (PDF)

OC.16.1 INTERLEUKIN-17A HOMODIMER REDUCES PRO-INFLAMMATORY CYTOKINE PRODUCTION BY INFLAMMATORY BOWEL DISEASE MUCOSA CULTURED EX VIVO

Digestive and liver disease, 2014-03, Vol.46, p.S34-S34

2014

Volltextzugriff (PDF)

T.11.10: PERCEPTION OF THE ROLE OF DIET ON SYMPTOM EXACERBATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2024-04, Vol.56, p.S282-S282

2024

Volltextzugriff (PDF)

P.05.8 CHROMOGRANIN A IN THE DUODENAL MUCOSA AND SERUM OF PATIENTS WITH PRE-MALIGNANT AND MALIGNANT COMPLICATIONS OF COELIAC DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S121-S121

2013

Volltextzugriff (PDF)

OC.07.2 SELECTIVE INHIBITION OF RIP2 KINASE ACTIVITY REDUCES PRO-INFLAMMATORY CYTOKINE PRODUCTION IN INFLAMMATORY BOWEL DISEASE MUCOSA

Digestive and liver disease, 2013-03, Vol.45, p.S71-S71

2013

Volltextzugriff (PDF)

OC.07.1 MICRO-RNA EXPRESSION PROFILING IDENTIFIES MIR-29B AS A RELEVANT PRO-FIBROGENIC FACTOR IN CROHN'S DISEASE INTESTINAL STRICTURES

Digestive and liver disease, 2013-03, Vol.45, p.S70-S71

2013

Volltextzugriff (PDF)

P.03.15 ACTIVATION OF TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 INCREASES THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES IN INFLAMMATORY BOWEL DISEASE MUCOSA

Digestive and liver disease, 2013-03, Vol.45, p.S110-S110

2013

Volltextzugriff (PDF)

T.01.5 APPLICATION OF A NOVEL SWALLOWABLE TELEMETRIC DEVICE FOR REAL TIME LUMINAL BLOOD DETECTION TO GUIDE TIMING OF ENTEROSCOPY IN A PATIENT WITH OBSCURE-OCCULT GASTROINTESTINAL BLEEDING: A CASE REPORT

Digestive and liver disease, 2023-03, Vol.55, p.S135-S136

2023

Volltextzugriff (PDF)

Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease

Gut, 2009-12, Vol.58 (12), p.1629-1636

2009

Volltextzugriff (PDF)

P1183 Perception of the role of diet on symptom exacerbation in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i2109-i2109

2024

Volltextzugriff (PDF)

T.02.10: “SMART GLASSES” FOR FIRST TIME GASTROSTOMY TUBE REPLACEMENT AT HOME BY A SPECIALIST ENDOSCOPY NURSE: INITIAL EXPERIENCE

Digestive and liver disease, 2024-04, Vol.56, p.S230-S231

2024

Volltextzugriff (PDF)

OC.09.8: PREMEDICATION WITH A NOVEL CLEANSING SOLUTION CONTAINING SIMETHICONE, N-ACETYLCYSTEINE AND ACETIC ACID IMPROVES VISUALIZATION DURING UPPER GI ENDOSCOPY: A DOUBLE-BLIND, MULTICENTER, RANDOMIZED CONTROLLED TRIAL

Digestive and liver disease, 2024-04, Vol.56, p.S180-S180

2024

Volltextzugriff (PDF)

P.12.22 MARKED ACTIVATION OF MUCOSAL PRO-INFLAMMATORY IMMUNE RESPONSE IN DIVERTICULITIS BUT NOT IN DIVERTICULOSIS

Digestive and liver disease, 2013-03, Vol.45, p.S180-S180

2013

Volltextzugriff (PDF)

P.05.7 ALTERED EXPRESSION OF TYPE-1 AND TYPE-2 CANNABINOID RECEPTORS IN COELIAC DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S121-S121

2013

Volltextzugriff (PDF)

P.03.5 IN VIVO FORMATION OF 8-ISO-PROSTAGLANDIN F2A AND PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S106-S106

2013

Volltextzugriff (PDF)

P.03.4 SERUM HEPCIDIN IN INFLAMMATORY BOWEL DISEASES

Digestive and liver disease, 2013-03, Vol.45, p.S106-S106

2013

Volltextzugriff (PDF)

P.11.8 CLINICAL CHARACTERIZATION OF PATIENTS WITH NON-CELIAC GLUTEN SENSITIVITY

Digestive and liver disease, 2012-03, Vol.44, p.S156-S156

2012

Volltextzugriff (PDF)

P.12.14 HIGH PREVALENCE OF HYPOSPLENISM IN PATIENTS WITH INCIDENTAL FINDING OF SMALL SPLEEN AT ABDOMINAL ULTRASOUND (US) PERFORMED FOR GASTROINTESTINAL (GI) DISORDERS

Digestive and liver disease, 2012-03, Vol.44, p.S165-S165

2012

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(139)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease

Serum regenerating islet‐derived 3‐alpha is a biomarker of mucosal enteropathies

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease

OC.02.2 HUMAN NEUTROPHIL ELASTASE CONTRIBUTES TO LOSS OF FUNCTION OF INFLIXIMAB IN ULCERATIVE COLITIS

V.01.3 CHOLANGIOSCOPIC REMOVAL OF POST-CHOLECYSTECTOMY SURGICAL CLIPS MIGRATED INTO THE COMMON HEPATIC DUCT

P.06.8 T HELPER 2 CELLS ARE NOT INCREASED, WHEREAS NATURAL KILLER T CELLS ARE REDUCED IN THE INFLAMED MUCOSA OF ULCERATIVE COLITIS PATIENTS

OC.16.3 THE ROLE OF HUMAN NEUTROPHIL ELASTASE AND ITS INHIBITOR ELAFIN IN ULCERATIVE COLITIS

P.11.1 THYMIC STROMAL LYMPHOPOIETIN IS PRIMARILY REDUCED IN REFRACTORY COELIAC DISEASE DUODENAL MUCOSA

OC.16.1 INTERLEUKIN-17A HOMODIMER REDUCES PRO-INFLAMMATORY CYTOKINE PRODUCTION BY INFLAMMATORY BOWEL DISEASE MUCOSA CULTURED EX VIVO

T.11.10: PERCEPTION OF THE ROLE OF DIET ON SYMPTOM EXACERBATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

P.05.8 CHROMOGRANIN A IN THE DUODENAL MUCOSA AND SERUM OF PATIENTS WITH PRE-MALIGNANT AND MALIGNANT COMPLICATIONS OF COELIAC DISEASE

OC.07.2 SELECTIVE INHIBITION OF RIP2 KINASE ACTIVITY REDUCES PRO-INFLAMMATORY CYTOKINE PRODUCTION IN INFLAMMATORY BOWEL DISEASE MUCOSA

OC.07.1 MICRO-RNA EXPRESSION PROFILING IDENTIFIES MIR-29B AS A RELEVANT PRO-FIBROGENIC FACTOR IN CROHN'S DISEASE INTESTINAL STRICTURES

P.03.15 ACTIVATION OF TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 INCREASES THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES IN INFLAMMATORY BOWEL DISEASE MUCOSA

T.01.5 APPLICATION OF A NOVEL SWALLOWABLE TELEMETRIC DEVICE FOR REAL TIME LUMINAL BLOOD DETECTION TO GUIDE TIMING OF ENTEROSCOPY IN A PATIENT WITH OBSCURE-OCCULT GASTROINTESTINAL BLEEDING: A CASE REPORT

Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease

P1183 Perception of the role of diet on symptom exacerbation in patients with Inflammatory Bowel Disease

T.02.10: “SMART GLASSES” FOR FIRST TIME GASTROSTOMY TUBE REPLACEMENT AT HOME BY A SPECIALIST ENDOSCOPY NURSE: INITIAL EXPERIENCE

OC.09.8: PREMEDICATION WITH A NOVEL CLEANSING SOLUTION CONTAINING SIMETHICONE, N-ACETYLCYSTEINE AND ACETIC ACID IMPROVES VISUALIZATION DURING UPPER GI ENDOSCOPY: A DOUBLE-BLIND, MULTICENTER, RANDOMIZED CONTROLLED TRIAL

P.12.22 MARKED ACTIVATION OF MUCOSAL PRO-INFLAMMATORY IMMUNE RESPONSE IN DIVERTICULITIS BUT NOT IN DIVERTICULOSIS

P.05.7 ALTERED EXPRESSION OF TYPE-1 AND TYPE-2 CANNABINOID RECEPTORS IN COELIAC DISEASE

P.03.5 IN VIVO FORMATION OF 8-ISO-PROSTAGLANDIN F2A AND PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE

P.03.4 SERUM HEPCIDIN IN INFLAMMATORY BOWEL DISEASES

P.11.8 CLINICAL CHARACTERIZATION OF PATIENTS WITH NON-CELIAC GLUTEN SENSITIVITY

P.12.14 HIGH PREVALENCE OF HYPOSPLENISM IN PATIENTS WITH INCIDENTAL FINDING OF SMALL SPLEEN AT ABDOMINAL ULTRASOUND (US) PERFORMED FOR GASTROINTESTINAL (GI) DISORDERS

Suchergebnisse filtern